Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder; a new report said that plasma lyso-sphingomyelin levels can be used to not only diagnose the rare disease but also predict ...

Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible for PEA PME), a next-generation biopharmaceutical company developing innovative therapies in sepsis and critical care based on an ...

A team at Helmholtz Munich and the Technical University of Munich (TUM) has developed a new microscopy technique that can ...

Researchers resent a new molecule for visualizing the sphingomyelin metabolism. This offers prospects for innovative therapeutic approaches in infection research. At the end of the 19th century, the ...

Sphingolipids are best known as lipids enriched in membrane microdomains and as signaling mediators. Contreras et al. now ascribe a cofactor function to the sphingolipid SM 18. Starting with the ...

Phase I pharmacokinetic and pharmacodynamic results of novel anti-neutropenic factor for the prevention and treatment of febrile neutropenia. This is an ASCO Meeting Abstract from the 2016 ASCO Annual ...

Scientists from Würzburg and Berlin have created a novel sphingomyelin derivative that allows visualization of sphingomyelin metabolism and sphingomyelinase activity in infection processes. This ...

New fluorescent lipids demonstrate how specialized regions in the cell membrane function, explain researchers in a new report. Researchers in Japan, India and France have found that molecules move ...

Novel trifunctional sphingomyelins (TFSM) can be used to visualise Chlamydia inclusions within infected human cells and enables the detection of native sphingomyelin derivatives in non-infectious ...

Phase I study of the combination of balixafortide (CXCR4 inhibitor) and eribulin in HER2-negative metastatic breast cancer (MBC) patients (pts). This is an ASCO Meeting Abstract from the 2017 ASCO ...